EPICS Therapeutics
epicstherapeutics.com
Actively hiring
Exhibitions
Oncology Therapeutics
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Overview
EPICS Therapeutics pioneers best-in-class small-molecule modulators of RNA epigenetics, with lead program EP102, a METTL3 inhibitor now advancing in patients with solid tumors.